HIGHLIGHTS
- who: Idiopathic Short Stature(ISS and colleagues from the Department of Gynecology and Obstetrics Qingyang, Gansu Province, PRChina have published the paper: Significance of recombinant human growth hormone therapy in promoting growth and development of children with stature, in the Journal: (JOURNAL) of April/13,/2022
- what: The aim of this retrospective study was to further explore the effect of exogenous rhGH therapy in promoting growth and development of children with Idiopathic Short Stature(ISS).
- how: Basic information of children and the following indicators were collected before treatment and after 12 months of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.